PERRY ANDREW (Chief Commercial Officer) sold 1.2% of their position (1.34K shares) of G1 THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2024ACC: 0001562180-24-005660
Officer· Chief Commercial Officer
Since Aug 2021
-1.34K
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.34K
Price / share
$2.51
Trade value
$3.35K
% of position
1.2%
7/5/2024
113.95K→112.61K
Total
Net shares
−1.34K
Net value
-$3.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2024 | S · Sale | −1.34K | $2.51 | $3.35K | 1.2% | 113.95K | 112.61K |
| Total | −1.34K | -$3.35K | ||||||
Derivative Transactions0
No derivative transactions reported